MannKind participates in UBS and Jefferies investor conferences

MNKD•2026-11-10

MannKind CEO Michael Castagna and CFO Chris Prentiss will provide business updates at two London investor conferences on Nov. 17 and 18, 2026.

1. Conference schedule

Castagna and Prentiss are scheduled for a UBS Global Biopharma Conference fireside chat on Nov. 17, 2026, from 11:20 to 11:50 a.m. GMT. They are also scheduled to present at the Jefferies Global Healthcare Conference on Nov. 18, from 8:00 to 8:25 p.m. GMT.

MannKind participates in UBS and Jefferies investor conferences

1. Conference schedule

Related News

Clover Health announces availability of Form 10-Q for period ended Sept. 30, 2026

Dollar strengthens after US inflation data boosts Fed rate-hike expectations

Agnico Eagle expects 2026 shareholder returns to exceed 50% of free cash flow

TriMas delays third-quarter report as financial statements remain incomplete

Adobe expands Google partnership to integrate AI models into creative tools